[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Measles Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

October 2019 | 40 pages | ID: MF9E4C37B6D2EN
VPAResearch

US$ 1,699.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Measles Drug pipeline report- 2020 is an annual R&D review of Measles pipeline candidates. The report presents the current status of all major Measles therapeutic compounds. Detailed insights into Measles pipeline development, current status, companies, drug profiles and Measles preclinical and clinical trials are included.

2020 Measles Pipeline Market Insights
Measles disease overview, 2020 pipeline review, insights into leading companies, dominant mechanism of action, majority of administration route of Measles therapies, pipeline by phase and others are included.

Measles pipeline Drug profiles-
Active and inactive drug profiles covering information including drug name/synonym, sponsor/collaborators/Developer/originator, drug mechanism, route of administration, orphan drug status, NME, phase, development status, and others are included.

Measles Therapeutic Drug candidates
Both active and inactive Measles pipeline drug candidates are included in the report

Measles Clinical Trials and preclinical Studies
Measles In-vitro and In-vivo studies, discovery stage and pre-clinical stage trial details, Clinical trial titles, duration, location, phase, sponsors, and other details are provided.

Measles pipeline market developments
Measles Pipeline market news and deals including mergers, acquisitions, approvals, collaborations, trial initiations, results, investments, licensing opportunities and others are provided.

Measles pipeline companies in active development
The report analyzes Measles pipeline of the below companies-

Biological E Limited, Cadila Healthcare Ltd, GlaxoSmithKline Plc, Japan Vaccine Co Ltd, Sinovac Biotech Ltd, VBI Vaccines Inc

Report Coverage

What to look out for in 2020
Drugs moving from early stage to mid-to-late stages and drugs to look after in 2020 are included

Pipeline Snapshot
Pipeline candidate count - Drug by phase, mechanism of action, route of administration, designation and others

Companies
6 Companies investing in Measles pipeline from discovery stage to pre-registration phase are included

Drug profiles
Over 10 details of each Measles pipeline candidate are included

Company Profiles
Business overview and contact details of all companies operating in the industry are provided

Market Developments
News, Developments and other recent industry developments are included
1. MEASLES PIPELINE MARKET INSIGHTS, 2020

1.1 Measles Disease Overview
1.2 Measles Drug Pipeline Snapshot, 2020
  1.2.1 Measles Pipeline Drugs by Phase
  1.2.2 Measles Pipeline Drugs by Company
  1.2.3 Measles Pipeline Drugs by Mechanism of Action
  1.2.4 Measles Pipeline Drugs by Route of Administration

2. MEASLES COMPANY WISE PIPELINE DETAILS

Biological E Limited Measles Pipeline Drugs
  Company Profile
  Drug Candidate Details
Cadila Healthcare Ltd Measles Pipeline Drugs
  Company Profile
  Drug Candidate Details
GlaxoSmithKline Plc Measles Pipeline Drugs
  Company Profile
  Drug Candidate Details
Japan Vaccine Co Ltd Measles Pipeline Drugs
  Company Profile
  Drug Candidate Details
Sinovac Biotech Ltd Measles Pipeline Drugs
  Company Profile
  Drug Candidate Details
VBI Vaccines Inc Measles Pipeline Drugs
  Company Profile
  Drug Candidate Details

3. MEASLES DRUG PIPELINE PROFILES

3.1 Discovery and Preclinical Drug Profiles
3.2 Phase 1 Drug Profiles
3.3 Phase 2 Drug Profiles
3.4 Phase 3 Drug Profiles

4. MEASLES PIPELINE NEWS AND DEVELOPMENTS

5. APPENDIX

5.1 Primary and Secondary Research Methodology
5.2 Publisher Expertize
5.3 Contacts


More Publications